A new drug called daraxonrasib targets a previously untreatable protein in pancreatic cancer cells, significantly extending patients' lives with late-stage disease.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Pancreatic Cancer Breakthrough Drug Extends Lives of Patients with Late-Stage Disease: 'I Had a Full Year of Normalcy'
Pancreatic Cancer Cells Drug targets previously untreatable protein
Expanded Access Approved FDA status
Full Year Of Normalcy Patient outcome
Sen. Ben Sasse Treated Political figure